1.
Cricket paralysis virus internal ribosome entry site-derived RNA promotes conventional vaccine efficacy by enhancing a balanced Th1/Th2 response
by Kwak, Hye Won
Vaccine, 2019, Vol.37 (36), p.5191-5202

2.

3.
Immunological features that associate with the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2
by Kageyama, Takahiro
Vaccine, 2022, Vol.40 (14), p.2129-2133

4.
Safety and immunogenicity of a quadrivalent seasonal influenza vaccine adjuvanted with hydroxypropyl-β-cyclodextrin: A phase 1 clinical trial
by Watanabe, Akane
Vaccine, 2022, Vol.40 (31), p.4150-4159

5.

6.

7.

8.
Effect of immune regulatory pathways after immunization with GMZ2 malaria vaccine candidate in healthy lifelong malaria-exposed adults
by Nouatin, Odilon
Vaccine, 2020, Vol.38 (27), p.4263-4272

9.
Long-term mucosal T cell activation and homing phenotypes in recipients of an Ad5-vectored HIV vaccine
by Curlin, Marcel E
Vaccine, 2020, Vol.38 (36), p.5814-5821

10.
An in vitro functional assay to measure the biological activity of TB vaccine candidate H4-IC31
by Ming, Marin
Vaccine, 2019, Vol.37 (22), p.2960-2966

11.
Anti-glioma effect of intracranial vaccination with tumor cell lysate plus flagellin in mice
by Dong, Boqi
Vaccine, 2018, Vol.36 (52), p.8148-8157

12.
Respiratory syncytial virus suppression of the antiviral immune response: Implications for evaluation of candidate vaccines
by Roberts, Norbert J
Vaccine, 2019, Vol.37 (51), p.7451-7454

13.
Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania
by Bakari, Muhammad
Vaccine, 2011, Vol.29 (46), p.8417-8428

14.

15.

16.
Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination
by Pakkanen, Sari H
Vaccine, 2012, Vol.30 (42), p.6047-6053

17.

18.
Ki-67 expression reveals strong, transient influenza specific CD4 T cell responses after adult vaccination
by Li, Xi
Vaccine, 2012, Vol.30 (31), p.4581-4584

19.
Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines
by Gil, Cristina
Vaccine, 2011, Vol.29 (34), p.5711-5724

20.
Complex cytokine responses to hepatitis B surface antigen and tetanus toxoid in responders, nonresponders and subjects naive to hepatitis B surface antigen
by Larsen, Charles E
Vaccine, 2000, Vol.18 (26), p.3021-3030
